No abstract

Osteoporosis is a disease that affects an increasing number of people, given the tendency of aging populations. Fragile bone and increases risk of bones breaking, their consequences, impairment of quality of life have prompted health policies to provide a greater insight into this condition. It is important to identify the risk factors and start the preventive and curative treatment as early as possible. Current guidelines recommend using the FRAX score to determine the risk of major fracture over the next 10 years, followed by DXA determination. The current guidelines highlight the importance of non-medication measures, calcium and vitamin D intake. Among the therapeutic agents used in the treatment of osteoporosis, the first line are bisphosphonates poor, in case of intolerance, bisphosphonates iv or antibodies anti RANKL (denosumab). Selective estrogen receptor modulators and hormone replacement therapy are not routinely indicated, and recombinant PTH is expensive and is intended for severe and resistant forms. The adherence to treatment is poor, so we need measures to increase prevention, screening and early treatment of osteoporosis, as well as measures to educate the population.

No abstract

In the current conditions of life, the analysis of mental illness must be defined through the lens of human relationships with environmental, social, cultural, and dynamic factors that substantially impact human mental balance. The study aims to analyze the correlations between depression and anxiety and different socio-demographic factors such as age, sex, background, occupation, identification of the medical impact (number of hospitalizations and number of days of hospitalization), presence of comorbidities and different methods of therapy, from the point of view of the therapeutic response. All these bio-psycho-social indicators translate relevant aspects of the disease on the population's quality of life.